CD8A and neoplasm: In conclusion, this work examined how multiple factors such as dose, route, presence of an antigen-expressing tumor entity, and heterologous vaccine partners influence the frequency and effector subtype composition of transgene- and vector-specific CD8+ T cells in mice, thereby providing a basic qualitative CD8+ T cell characterization of VSV-GP.